Zobrazeno 1 - 10
of 15
pro vyhledávání: '"фокальные приступы"'
Autor:
V. E. Kitaeva, A. S. Kotov
Publikováno v:
Русский журнал детской неврологии, Vol 15, Iss 3-4, Pp 10-18 (2021)
Background. The status epilepticus of focal impaired-awareness seizures (SE FIAS) is a series of focal seizures with loss or change of consciousness, between which there is no complete recovery of consciousness. This status epilepticus occurs in pati
Externí odkaz:
https://doaj.org/article/6817796762354a498c906bd65f994801
Publikováno v:
Русский журнал детской неврологии, Vol 14, Iss 4, Pp 17-25 (2020)
Background. Comparative study of antiepileptic drugs allows to make the optimal choice in therapy.The aim of the study: a comparative analysis of the administration of two similar by chemical structure antiepileptic drugs (zonisamide and topiramate)
Externí odkaz:
https://doaj.org/article/4ee3c37f75284c62bdf078a268ee8308
Publikováno v:
Русский журнал детской неврологии, Vol 13, Iss 3, Pp 36-44 (2018)
Externí odkaz:
https://doaj.org/article/275ad43e062c49fb8c5a0843cec5ad39
Autor:
K. Yu. Mukhin, O. A. Pylaeva
Publikováno v:
Русский журнал детской неврологии, Vol 11, Iss 2, Pp 52-62 (2016)
Despite a considerable advance made in epileptology, resistant epilepsies account for approximately 30 % of all forms of epilepsy particularly in patients with focal seizures. The most common structural cause of resistant epilepsies in children is fo
Externí odkaz:
https://doaj.org/article/bcd51a4a2ef048bc88f878fefb53481d
Publikováno v:
Русский журнал детской неврологии, Vol 10, Iss 3, Pp 37-42 (2015)
Although epileptologists have a lot of antiepileptic drugs (AEDs) at their disposal now and there are more than 10 novel AEDs; until the present time, two groups of drugs (valproic acid and carbamazepine, which were designed in the 1970s) have remain
Externí odkaz:
https://doaj.org/article/9a4784c9578e457b94de3c395e7d8707
Autor:
O. A. Pylaeva, K. Yu. Mukhin
Publikováno v:
Русский журнал детской неврологии, Vol 9, Iss 2, Pp 42-49 (2015)
Despite a considerable advance made in epileptology, resistant epilepsies are about 30 % among all epilepsy types. The paper reviews the current literature dealing with the efficacy and safety of the new antiepileptic drug zonisamide (Zonegran) in th
Externí odkaz:
https://doaj.org/article/3cb1e2872c8940caa9c091b11210eed8
Publikováno v:
Русский журнал детской неврологии, Vol 9, Iss 4, Pp 59-68 (2015)
Externí odkaz:
https://doaj.org/article/6bf2984a9b9c4bf6a16e44b7922833d8
Publikováno v:
Русский журнал детской неврологии, Vol 10, Iss 1, Pp 4-15 (2015)
Externí odkaz:
https://doaj.org/article/ac7e35fa17c74e119f98447436e35e27
Autor:
K. Yu. Мukhin, O. A. Pylaeva
Publikováno v:
Русский журнал детской неврологии, Vol 10, Iss 1, Pp 47-63 (2015)
Despite the significant progress made in epileptology, resistant epilepsies constitute approximately 30 % of all forms of epilepsy. An overview of recent literature is provided on the efficacy and safety of a new antiepileptic drug zonisamide (Zonegr
Externí odkaz:
https://doaj.org/article/f00afd96c1484b5689bed03cd8d920c0
Autor:
K. Yu. Mukhin, O. A. Pylaeva
Publikováno v:
Русский журнал детской неврологии, Vol 9, Iss 4, Pp 14-19 (2015)
Externí odkaz:
https://doaj.org/article/cf990ffdcd804539b74c86b3e02032ad